pubmed-article:16181331 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16181331 | lifeskim:mentions | umls-concept:C0521026 | lld:lifeskim |
pubmed-article:16181331 | lifeskim:mentions | umls-concept:C0015576 | lld:lifeskim |
pubmed-article:16181331 | lifeskim:mentions | umls-concept:C0178539 | lld:lifeskim |
pubmed-article:16181331 | lifeskim:mentions | umls-concept:C0034800 | lld:lifeskim |
pubmed-article:16181331 | lifeskim:mentions | umls-concept:C0041538 | lld:lifeskim |
pubmed-article:16181331 | lifeskim:mentions | umls-concept:C0077678 | lld:lifeskim |
pubmed-article:16181331 | lifeskim:mentions | umls-concept:C0013081 | lld:lifeskim |
pubmed-article:16181331 | pubmed:dateCreated | 2005-9-26 | lld:pubmed |
pubmed-article:16181331 | pubmed:abstractText | The mK3, K3, and K5 gene products from the gamma2 group of gamma-herpesviruses are the founding members of a family of membrane-associated ubiquitin E3 ligases. As part of the viral immunoevasion strategy, expression of these proteins results in a decrease in cell-surface major histocompatibility complex class I molecules and other immunoreceptors including intercellular adhesion molecule-1, CD86, and CD1d. These viral gene products all possess a characteristic cytosolic N-terminal RING-CH domain, responsible for ubiquitination of the target protein, and two membrane-spanning segments required for substrate specificity. For the majority of substrates, ubiquitination at the cell surface leads to rapid internalization and endolysosomal degradation, while mK3 ubiquitinates class I molecules associated with the peptide-loading complex resulting in proteasome-mediated degradation. Related viral genes with similar functions have been found in poxviruses, suggesting appropriation of these genes from the eukaryotic host. Ten membrane-associated RING-CH (MARCH) human genes with a similar organization have now been identified, and their overexpression leads to ubiquitination and downregulation of a variety of cell-surface immunoreceptors. While all the MARCH proteins are predicted to act as ubiquitin E3 ligases, their physiological role and substrates remain to be defined. | lld:pubmed |
pubmed-article:16181331 | pubmed:language | eng | lld:pubmed |
pubmed-article:16181331 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16181331 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16181331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16181331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16181331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16181331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16181331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16181331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16181331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16181331 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16181331 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16181331 | pubmed:issn | 0105-2896 | lld:pubmed |
pubmed-article:16181331 | pubmed:author | pubmed-author:LehnerPaul... | lld:pubmed |
pubmed-article:16181331 | pubmed:author | pubmed-author:DoddRogerR | lld:pubmed |
pubmed-article:16181331 | pubmed:author | pubmed-author:DuncanLidia... | lld:pubmed |
pubmed-article:16181331 | pubmed:author | pubmed-author:HoerSimonS | lld:pubmed |
pubmed-article:16181331 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16181331 | pubmed:volume | 207 | lld:pubmed |
pubmed-article:16181331 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16181331 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16181331 | pubmed:pagination | 112-25 | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:meshHeading | pubmed-meshheading:16181331... | lld:pubmed |
pubmed-article:16181331 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16181331 | pubmed:articleTitle | Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. | lld:pubmed |
pubmed-article:16181331 | pubmed:affiliation | Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, UK. pjl30@cam.ac.uk | lld:pubmed |
pubmed-article:16181331 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16181331 | pubmed:publicationType | Review | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16181331 | lld:pubmed |